AC Immune Ltd (ACIU) Now Covered by Analysts at Jefferies Group
Stock analysts at Jefferies Group began coverage on shares of AC Immune Ltd (NASDAQ:ACIU) in a report released on Tuesday, The Fly reports. The brokerage set a “buy” rating on the stock.
AC Immune (NASDAQ:ACIU) opened at 14.43 on Tuesday. The firm’s 50-day moving average price is $16.17 and its 200 day moving average price is $16.17. The company has a market cap of $712.78 million and a PE ratio of 31.17. AC Immune has a 52-week low of $13.01 and a 52-week high of $19.97.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/ac-immune-ltd-aciu-now-covered-by-analysts-at-jefferies-group.html
Receive News & Ratings for AC Immune Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune Ltd and related companies with MarketBeat.com's FREE daily email newsletter.